FIELD: pharmacology.
SUBSTANCE: invention relates to the crystalline form of grapiprant selected from the group consisting of Form X, Form X2, Form X3, Form F, Form K, Form L, Form M and Form N.
EFFECT: new crystalline form of grapiprant, as well as pharmaceutical compositions suitable for treatment of pain, inflammation, arthritis and cancer, and methods to obtain them.
8 cl, 13 tbl, 23 dwg, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| S-CRYSTAL FORM OF IVABRADINE HYDROCHLORIDE, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION THEREOF | 2014 |
|
RU2658824C2 |
| POLYMORPHIC FORM OF SODIUM HYODEOXYCHOLATE (NAHDC) AND PREPARATION PROCESS THEREOF | 2014 |
|
RU2669785C2 |
| BILASTIN CRYSTALLINE FORMS AND THEIR PRODUCTION METHODS | 2016 |
|
RU2772222C2 |
| SALTS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASE | 2013 |
|
RU2711077C2 |
| SOLID FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR | 2013 |
|
RU2673077C2 |
| DIMETHYLAMINOCHELIOLIDE FUMARATE HYDRATE AND METHOD FOR PREPARATION THEREOF, AND USE THEREOF | 2020 |
|
RU2824144C1 |
| CRYSTALLINE FORM OF 6-[(4R)-4-METHYL-1,1-DIOXIDO-1,2,6-THIADIAZINAN-2-YL]ISOQUINOLINE-1-CARBONITRILE | 2015 |
|
RU2698194C2 |
| CRYSTALLINE FORM AND SALT FORM OF A PYRIDOIMIDAZOLE COMPOUND AND A CORRESPONDING METHOD OF PRODUCING | 2019 |
|
RU2769050C1 |
| NOVEL CRYSTALLINE FORMS OF SODIUM SALT OF (4-{4-[5-(6-TRIFLUOROMETHYL-PYRIDIN-3-YLAMINO)PYRIDIN-2-YL]PHENYL}CYCLOHEXYL) ACETIC ACID | 2011 |
|
RU2612556C2 |
| DOCETAXEL POLYMORPHS AND SYNTHESIS METHODS THEREOF | 2007 |
|
RU2437875C2 |
